Rinvoq (Upadacitinib)

Rinvoq

(Brand Option)

Prescription RequiredPrescription Required
FormulationFormulation: ER Tablet
Select Dosage

Select Quantity

$1,450.00 ($0.04 per tablet)

$2,550.00 ($0.07 per tablet)

Upadacitinib

(Generic Alternative)

Prescription RequiredPrescription Required

This generic medication is not available at the moment.

Norton Shopping Guarantee

Lower Costs and Easier Access

Enjoy the Canadian benefits of both.

You can buy Rinvoq from Canada on DoctorSolve.com without leaving the comfort of your home. DoctorSolve™ has been a trustworthy choice for online pharmacy needs in the United States since 1999.

We offer competitive Canadian prices for Rinvoq, helping you save thousands of dollars on your medication each year. DoctorSolves™ reputation for exceptional service is backed by a remarkable 4.8/5 customer rating and 655+ positive reviews.

DoctorSolve™ is verified by Canadian International Pharmacy Association (CIPA) and International Pharmacy Association of British Columbia (IPABC). We prioritize your health by requiring a valid prescription from a healthcare provider, ensuring Rinvoq is appropriate for your condition.

If you prefer speaking to a support staff, call +1-866-732-0305 to order Rinvoq or fax your prescription to 1-877-251-1650. Our support staff are prompt and will answer all your queries professionally.

Rinvoq (upadacitinib) is indicated for the treatment of several conditions in adults and pediatric patients 12 years of age and older. It is used for the following conditions:

  1. Rheumatoid Arthritis: Rinvoq is used alone or with other medications to treat rheumatoid arthritis in people who are unable to take or have not responded well to one or more tumor necrosis factor (TNF) inhibitor medication(s).
  2. Psoriatic Arthritis: It is also used to treat psoriatic arthritis in adults who are unable to take or did not respond to or tolerate one or more TNF inhibitor medication(s).
  3. Eczema (Atopic Dermatitis): Rinvoq is used to treat symptoms of eczema in adults and children 12 years and older who cannot use other medications for their condition or whose eczema has not responded to other medications.
  4. Ankylosing Spondylitis: For the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers.
  5. Non-radiographic Axial Spondyloarthritis: Rinvoq is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation who have had an inadequate response or intolerance to TNF blocker therapy.

Do’s

  • Before starting Rinvoq, read the Medication Guide and, if available, the Patient Information Leaflet provided by your pharmacist. 
  • Rinvoq is typically taken once daily, with or without food, as directed by your healthcare provider. The dosage is based on your medical condition, response to treatment, age, and other medications you may be taking. Follow your healthcare provider's prescribed dosage.
  • Rinvoq should be taken by mouth and swallowed whole. Take it regularly at the same time each day to get the most benefit from it. If you have any questions about the administration of Rinvoq, consult your healthcare provider.
  • Inform your healthcare provider about all the products you use, including prescription drugs, nonprescription drugs, herbal products, and supplements, as they may interact with Rinvoq. 
  • Avoid eating grapefruit or drinking grapefruit juice while using Rinvoq, unless your healthcare provider says it's safe to do so, as grapefruit can increase the chance of side effects with this medication.

Don’ts

  • Do not increase the prescribed dosage without your healthcare provider’s guidance.
  • Rinvoq should not be crushed, chewed, or split, as doing so can release all of the drug at once, increasing the risk of side effects.

Common Side Effects: 

  • Cough
  • Fever
  • Nausea
  • Upper respiratory tract infections, such as the common cold.

These side effects are usually temporary, lasting for a few days or weeks. However, if they persist, become severe, or cause concern, discuss them with a healthcare provider.

Some people taking Rinvoq may see medicine residue (a whole tablet or tablet pieces) in their stool, which should be reported to a healthcare provider.

This is not an exhaustive list, and other side effects may occur. If you experience any unusual or severe side effects while taking Rinvoq, contact your healthcare provider for medical advice.

Do not take Rinvoq if you are allergic to upadacitinib or any of the ingredients in Rinvoq. Review the Medication Guide or Consumer Brief Summary for a complete list of ingredients. If you experience symptoms of an allergic reaction, such as rash, itching, swelling, severe dizziness, or trouble breathing, seek immediate medical attention.

Patients treated with Rinvoq are at an increased risk of developing infections that may lead to hospitalization or death. These infections include tuberculosis (TB) and invasive fungal, bacterial, viral, and other infections due to opportunistic pathogens. Inform your healthcare provider if you are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection, such as fever, sweating, chills, shortness of breath, and more. Rinvoq treatment should be interrupted if a serious infection develops until the infection is controlled.

A separation or tear to the lining of the back part of the eye (retinal detachment) has happened in people with atopic dermatitis treated with Rinvoq. Contact a healthcare provider right away if any sudden vision changes occur during treatment with Rinvoq.

Rinvoq can weaken the immune system, lowering the likelihood that the body will respond properly to vaccines. Talk with a healthcare provider before getting any vaccines while taking Rinvoq.

For more detailed information and guidance on the warnings and precautions associated with Rinvoq, individuals are encouraged to consult their healthcare provider and refer to the complete prescribing information and medication guide for Rinvoq.

Generic name:

Upadacitinib

Formulation:

ER Tablet

Strength(s): 15mg, 30mg
Quantities Available: 28, 30
Important Information
The information above for Rinvoq (Upadacitinib) was provided to DoctorSolve.com by third parties. In no way should this information substitute for the advice of a physician. Consult a doctor or qualified health care professional if you have any medical concerns.
Doctorsolve.com widget logo
Customer Care Customer Care

Excellent Customer Care We Are Here for You

Guiding you every step of the way, ensuring access to affordable medicines. Our customer service team is available seven days a week to answer any questions or to address any concerns you may have. Please give us a call at Doctor Solve on Monday to Friday from 6am-8pm PST, or Saturdays and Sundays from 7am-5pm PST.

CALL US